USPTO serial 79291176
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Claudia A. Smith
Claudia A. Smith White & Case LLP1221 Avenue of the AmericasTrademark DepartmentNew York, NY 10020| Class | Description | Status | First use |
|---|---|---|---|
| 041 | Educational services, namely, arranging and conducting classes and workshops in the field of science and research relating central nervous system diseases and disorders; providing of training in the field of student competitions in the field of science and research regarding central nervous system diseases and disorders; entertainment, namely, arranging and conducting student competitions in the field of science and research involving the creation of posters regarding central nervous system diseases and disorders; entertainment services, namely, live events in the nature of student competitions involving research in the field of central nervous system diseases and disorders and the creation of posters regarding same; educational and entertainment services in the nature of providing non-downloadable videos and images available from websites, social media platforms, and computer applications, featuring research regarding central nervous system diseases and disorders and student poster competitions regarding same; educational and entertainment services in the nature of providing non-downloadable videos and images in the field of health and medicine provided through a website, social media platforms and computer applications | ABANDONED | — |
| 042 | Pharmaceutical research and development; scientific and technological services, namely, research and design in the field of the central nervous system and central nervous system related disorders and diseases and pharmaceuticals; medical research; diagnostic testing for research and scientific purposes; medical and scientific research and conducting clinical trials; scientific and medical research, namely, performing diagnostic research and tests; providing on-line non-downloadable screening tools in the nature of software for assessing cognitive functions and assessing psychiatric and neurological disorders and diseases; providing online non-downloadable screening tools in the nature of software for diagnosing, managing, monitoring, assessing, controlling and examining psychiatric and neurological disorders and diseases | ABANDONED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 20, 2022 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 30, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 30, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 30, 2021 | MAB5 | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION | — |
| Aug 30, 2021 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Aug 25, 2021 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Mar 16, 2021 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Mar 15, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 2, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 2, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 24, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 24, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 10, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 25, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 25, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 25, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 25, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 25, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 22, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 22, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 22, 2021 | ALIE | ASSIGNED TO LIE | — |
| Oct 20, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 4, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 15, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 15, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 19, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 18, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 18, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 17, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 14, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 14, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 13, 2020 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Aug 6, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |